EFFECT OF POLYMORPHISM ON NEW DRUG FORMULATION AND DEVELOPMENT: A SHORT REVIEW

Authors

  • SHAKTHIVEL.K Student Faculty of Pharmacy, Bharath Institute of Higher Education and Research, Chennai.
  • DEVI.R Assistant Professor Faculty of Pharmacy, Bharath Institute of Higher Education and Research, Chennai
  • Dr. R. SRINIVASAN Professor Faculty of Pharmacy, Bharath Institute of Higher Education and Research, Chennai.
  • SAM DAVID.E Student Faculty of Pharmacy, Bharath Institute of Higher Education and Research, Chennai.

DOI:

https://doi.org/10.58260/j.ppmr.2202.0104

Keywords:

Polymorphism, polymorphs, Active pharmaceutical ingredient, bioavailability, preclinical studies

Abstract

The polymorphism of pharmaceutically active drugs has a major impact in the formulation, development and introducing it into the market. Manufacturing a stable and potent active pharmaceutical ingredient, is an important role of pharmacists, and it could be made by research and evaluation of polymorphs that might be probably studied on the drug. The objective of polymorphism and its application is to create a better product, and avoid manufacturing issues by studying the polymorphs of various drugs and the differences between their polymorphic forms. Polymorphism principally centers on solid pharmaceuticals and affects their characteristics such as melting point, boiling point, free energy, dissolution property, shelf life, viscosity, adsorption, bio availability, solubility etc., which may cause manufacturing difficulties of the drug. So, the data of polymorphism of drugs through various lab studies is essential to avoid them. In the case of production of a new drug, polymorphs of the drug have great influence from the production to the preclinical studies of the drug. Then the new drug enters the market after being subjected to tests which include considering the possible polymorphs of the drug and evaluating their stabilities for a longer shelf life and desirable therapeutic action. Polymorphism has been studied over more than 50 years and it still has a huge scope in the present and future of the pharmaceutical field.

References

Maria Saifee;Nazma Inamdar;Dinesh L Dhamecha; Amit A Rathi."Drug Polymorphism: A Review"from International journal of health research,poracom academic publishers,Year;2009.

Nirmal K shee;Shanthi G patra ;and Dipankar Datta."Polymorphism of Aspirin: A New Perspective ",Indian journal of chemical modelling Volume 7, Number 2;Year;2015

Rahul Purohit ; P Venugopalan "Polymorphism: An overview",Year;2009.

John F. Bauer,"Polymorphism—A CriticalConsideration in Pharmaceutical Development, Manufacturing, and Stability ,Pharmaceutical solids" Year;2008

Kaisar Raza; Pramod Kumar; Shanti Ratan;Ruchi Malik ;and Shweta Arora;"Polymorphism: The Phenomenon Affecting the Performance of Drugs"Year;2014.

Monika Kadela-Tomanek;Maria Jastrzebska;Ewa Bebenek;"Structural and spectral characterisation of 2-amino-2H-[1,2,3]triazolo[4,5-g]quinoline-4,9-dione polymorphs. Cytotoxic activity and molecular docking study with NQO1 enzyme" Year;2020.

Roberta Censi; Piera Di Martino "Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs "Year;2015.

Razia K; Kumar P:Ratan S;Malik R;Arora S ;Year ;(2014)" Polymorphism: The Phenomenon Affecting the Performance of Drugs" SOJ Pharm Pharm Sci, 1(2), 10.

Yanan Zhou: Jingkang Wang ; Yan Xiao ;Ting Wang ; Xin Huang;"The Effects of Polymorphism on Physicochemical Properties and Pharmacodynamics of Solid Drugs"Year; 2018.

Alfred Y. Lee ;Deniz Erdemir; Allan S. Myerson;"crystal polymorphism in chemical process development" in Annual Review of Chemical and Biomolecular Engineering Vol. 2:259-280 (Volume publication Year; 2011.

Dmitry Chistyakov; Gleb Sergeev;"The Polymorphism of Drugs: New Approaches to the Synthesis of Nanostructured Polymorphs"Year;2020.

Zhou, Y.; Wang, J.; Xiao, Y.; Wang, T.; Huang, X. "The Effects of Polymorphism on Physicochemical Properties and Pharmacodynamics of Solid Drugs" Year;2018.

"Polymorphism in pharmaceutical solids" by Harry G Brittain Drugs and the pharmaceutical sciences 95"Year; 1999.

Stephanie M Guthrie; Detlef-M Smilgies; Gaurav Giri."Controlling polymorphism in pharmaceutical compounds using solution shearing"Year;2018.

"Polymorphism in early development: The account of MBQ-167"by Jocelyn M Jiménez Cruz;Cornelis P Vlaar, Torsten Stelzer; Vilmalí López-Mejías International Journal of Pharmaceutics.Year;2021.

Published

2022-06-15

How to Cite

SHAKTHIVEL.K, DEVI.R, Dr. R. SRINIVASAN, & SAM DAVID.E. (2022). EFFECT OF POLYMORPHISM ON NEW DRUG FORMULATION AND DEVELOPMENT: A SHORT REVIEW. Global Journal of Pharma and Paramedical Research(PPMR) [ISSN: 2583-4479], 1(1), 40–44. https://doi.org/10.58260/j.ppmr.2202.0104

Issue

Section

Research Article